查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1700026

2032 年细胞培养基市场预测：按产品类型、细胞类型、配方类型、应用、最终用户和地区进行的全球分析

Cell Culture Media Market Forecasts to 2032 - Global Analysis By Product Type, Cell Type, Formulation Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球细胞培养基市场预计在 2025 年达到 66 亿美元，到 2032 年将达到 152.5 亿美元，预测期内的复合年增长率为 12.7%。

细胞培养基是富含营养的溶液，用于在实验室条件下支持细胞的生长、维持和增殖。培养基提供细胞在自然环境之外生长所需的必需营养素、维生素、胺基酸、盐和生长因子。根据细胞类型及其预期用途，培养基可以是化学定义的、基于血清的或无血清的。在试管内中检查和操作细胞的能力使得这些培养基在药物发现、再生医学、癌症研究和生物製药製造等多个领域中至关重要。

根据世界卫生组织估计，2021年全球将有128,000例麻疹病例和死亡病例，其中大多数是未接种疫苗或疫苗接种不足的五岁以下儿童。

生物製药需求不断成长

慢性病的增加和全球人口老化推动了对先进生物製药的需求不断增长。生物製药的生产需要高品质的细胞培养基，使得这个市场变得越来越重要。人们对生技药品和生物相似药的日益关注进一步推动了对高效细胞培养基的需求。此外，干细胞和再生医学等基于细胞的研究的增加正在加速市场成长。随着製药公司对研发的大力投入，细胞培养基市场正在稳步成长。

媒体发展的复杂性

细胞培养基开发是一个具有挑战性的过程，需要针对特定细胞株和应用客製化的复杂配方。研究、测试和开发客製化媒体的高成本可能会成为小型製造商的障碍。此外，对细胞培养产品的严格监管要求进一步增加了复杂性和成本。原材料的多变性和性能的不一致性给媒体开发商带来了额外的障碍。当公司努力满足行业标准时，所需的时间和资源可能会限制创新。

个人化医疗的采用日益增多

个人化医疗的重点是根据患者的个人情况提供客製化治疗，这对创新细胞培养基产生了巨大的需求。基因组学、蛋白质组学和细胞治疗的进步推动了针对特定应用而设计的培养基的需求。 CAR-T细胞疗法和其他基于细胞的疗法的兴起为培养基优化创造了更多机会。此外，人们对器官晶片技术和 3D 细胞培养的兴趣日益浓厚，拓宽了细胞培养基的应用范围。个人化医疗是细胞培养基市场的一个活跃成长领域。

技术纯熟劳工短缺

对细胞培养技术训练有素的专业人员的需求通常超过现有的人才库。人才短缺可能导致产品开发和品管效率低下和延误。此外，培训计画和教育措施不足也加剧了这个问题。缺乏专业知识会使公司难以保持一致性并满足监管标准。

COVID-19的影响：

COVID-19 疫情加速了对疫苗开发、治疗研究和诊断测试的需求，对细胞培养基市场产生了重大影响。人们对生物製药和 COVID-19 治疗的关注度不断提高，导致细胞培养基在病毒研究和疫苗生产中的使用量激增。然而，供应链中断，包括原材料采购延迟和生产瓶颈，暂时阻碍了市场成长。儘管面临这些挑战，但这场疫情凸显了细胞培养基在药物开发和生物技术中的关键作用。

预计合成媒体领域将成为预测期内最大的领域

由于合成培养基具有一致性、可重复性以及精确控制细胞生长条件的能力，预计在预测期内将占据最大的市场占有率。确定成分培养基消除了基于血清的配方所带来的可变性，并提供了更标准化的结果。此外，生物製药製造、干细胞研究和细胞疗法对无血清、化学成分确定的培养基的偏好日益增长，进一步加速了确定性培养基在各种应用中的应用。

预计肿瘤学研究在预测期内将以最高的复合年增长率成长

由于对有效的癌症治疗和早期诊断方法的需求不断增加，预计癌症研究领域将在预测期内见证最高的成长率。细胞培养基为癌细胞细胞株的培养提供了受控环境，从而实现了药物发现、肿瘤分析和个人化治疗开发。免疫疗法和标靶治疗的进步，以及人们对癌症生物学日益增长的兴趣，进一步推动了对癌症研究中特殊培养基的需求。

占比最大的地区：

预计亚太地区将在预测期内占据最大的市场占有率。这是由于生物技术和製药行业的扩张、医疗保健投资的增加以及对生物製药的需求不断增长。该地区对研发的日益重视，特别是在干细胞治疗、个人化医疗和癌症研究方面，也推动了市场的成长。此外，基础设施建设和政府加强医疗保健和生物技术领域的措施也促进了亚太地区对细胞培养基的需求不断增加。

复合年增长率最高的地区：

预计北美地区在预测期内将呈现最高的复合年增长率。这是因为该地区拥有强大的生物技术和製药产业以及对研发的大量投资。对生技药品、疫苗和个人化医疗的需求不断增长，推动了对先进细胞培养基的需求。此外，领先研究机构的存在、对癌症研究和细胞治疗的日益关注以及强大的医疗保健基础设施进一步促进了北美市场的成长。

免费客製化服务

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 对其他市场公司（最多 3 家公司）进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 地理细分
    • 根据客户兴趣对主要国家市场进行估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

第五章全球细胞培养基市场（依产品类型）

  • 大自然媒体
  • 合成媒体
  • 半合成培养基
  • 无血清培养基
    • CHO媒体
    • HEK 293 培养基
    • BHK中型
    • Velo中型
  • 自订媒体
  • 传统媒体
  • 化学成分确定的培养基
  • 其他产品类型

6. 全球细胞培养基市场（依细胞类型）

  • 哺乳动物细胞
  • 昆虫细胞
  • 微生物细胞
  • 初代细胞
  • 永生化细胞株

7. 全球细胞培养基市场（依配方类型）

  • 粉末製剂
  • 液体製剂
  • 集中

第八章全球细胞培养基市场（按应用）

  • 药物开发与测试
  • 再生医学
  • 生物製药製造
  • 癌症研究
  • 干细胞研究
  • 组织工程
  • 其他用途

第九章全球细胞培养基市场（依最终用户）

  • 製药和生物技术
  • 研究和学术机构
  • 合约研究组织（CRO）
  • 医院和诊断实验室
  • 其他最终用户

第 10 章全球细胞培养基市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Thermo Fisher Scientific, Inc.
  • Bio-Techne Corporation
  • Sigma-Aldrich
  • Merck Millipore
  • Lonza Group
  • Pan-Biotech GmbH
  • GE Healthcare Life Sciences
  • CellGenix GmbH
  • Corning Incorporated
  • Sartorius Stedim Biotech
  • BD Biosciences
  • HiMedia Laboratories
  • Samsung Biologics
  • Miltenyi Biotec
  • Fujifilm Irvine Scientific
Product Code: SMRC28929

According to Stratistics MRC, the Global Cell Culture Media Market is accounted for $6.60 billion in 2025 and is expected to reach $15.25 billion by 2032 growing at a CAGR of 12.7% during the forecast period. Cell culture media are nutrient-rich solutions used to support the growth, maintenance, and propagation of cells in laboratory conditions. They provide essential nutrients, vitamins, amino acids, salts, and growth factors required for cells to thrive outside their natural environment. Culture media can be chemically defined, serum-based, or serum-free, depending on the kind of cell and its intended use. The ability to examine and manipulate cells in vitro makes these media essential in a variety of sectors, such as drug discovery, regenerative medicine, cancer research, and biopharmaceutical production.

According to the WHO, in 2021, there were an estimated 128 000 measles deaths globally, mostly among unvaccinated or under vaccinated children under the age of 5 years.

Market Dynamics:

Driver:

Growing demand for biopharmaceuticals

The rising prevalence of chronic diseases and an aging global population are driving the need for advanced biopharmaceuticals. Biopharmaceuticals require high-quality cell culture media for their production, enhancing the importance of this market. The increasing focus on biologics and biosimilars further propels demand for efficient cell culture media. Moreover, the rise in cell-based research, such as stem cell and regenerative medicine, is accelerating the market's growth. With pharmaceutical companies investing heavily in R&D, the cell culture media market is witnessing steady growth.

Restraint:

Complexity in media development

Developing cell culture media involves intricate formulations tailored to specific cell lines and applications, making it a challenging process. The high costs associated with research, testing, and development of customized media can act as a barrier for small-scale manufacturers. Additionally, stringent regulatory requirements for cell culture products add to the complexity and expenses. Variability in raw materials and inconsistencies in performance create further hurdles for media developers. As companies strive to meet industry standards, the time and resources required can limit innovation.

Opportunity:

Increasing adoption of personalized medicine

Personalized medicine focuses on providing tailored treatments based on individual patient profiles, creating a significant demand for innovative cell culture media. Advances in genomics, proteomics, and cell therapies are driving the need for media designed for specific applications. The rise of CAR-T cell therapies and other cell-based treatments enhances opportunities for media optimization. Additionally, the growing interest in organ-on-chip technologies and 3D cell cultures expands the application of cell culture media. Personalized medicine represents a dynamic growth area for the cell culture media market.

Threat:

Lack of skilled labor

The demand for trained experts in cell culture techniques often outpaces the available talent pool. This talent gap can lead to inefficiencies and delays in product development and quality control. Moreover, insufficient training programs and educational initiatives exacerbate this problem. Companies may face difficulties in maintaining consistency and meeting regulatory standards due to the lack of expertise.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the cell culture media market by accelerating the demand for vaccine development, therapeutic research, and diagnostic tests. The increased focus on biopharmaceuticals and COVID-19 treatments led to a surge in the use of cell culture media for viral research and vaccine production. However, supply chain disruptions, including delays in raw material sourcing and production bottlenecks, temporarily hindered market growth. Despite these challenges, the pandemic highlighted the critical role of cell culture media in drug development and biotechnology.

The synthetic media segment is expected to be the largest during the forecast period

The synthetic media segment is expected to account for the largest market share during the forecast period, due to their consistency, reproducibility, and the ability to precisely control cell growth conditions. Synthetic media eliminate the variability associated with serum-based formulations, offering more standardized results. Additionally, the increasing preference for serum-free and chemically defined media for biopharmaceutical production, stem cell research, and cell-based therapies further accelerates the adoption of synthetic media in various applications.

The cancer research segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cancer research segment is predicted to witness the highest growth rate, due to the increasing need for effective cancer therapies and early diagnostic methods. Cell culture media provide a controlled environment for cultivating cancer cell lines, enabling drug discovery, tumor analysis, and personalized treatment development. Advancements in immunotherapy and targeted therapies, along with the growing focus on understanding cancer biology, further fuel the demand for specialized media in cancer research.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, driven by the expanding biotechnology and pharmaceutical industries, increased healthcare investments, and rising demand for biopharmaceuticals. The region's growing focus on research and development, particularly in stem cell therapies, personalized medicine, and cancer research, also boosts market growth. Additionally, improving infrastructure and government initiatives to enhance healthcare and biotechnology sectors contribute to the rising demand for cell culture media in Asia Pacific.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to the region's robust biotechnology and pharmaceutical industries, coupled with significant investments in research and development. The growing demand for biologics, vaccines, and personalized medicine fuels the need for advanced cell culture media. Additionally, the presence of leading research institutions, increasing focus on cancer research and cell-based therapies, and strong healthcare infrastructure further contribute to market growth in North America.

Key players in the market

Some of the key players in Cell Culture Media Market include Thermo Fisher Scientific, Inc., Bio-Techne Corporation, Sigma-Aldrich, Merck Millipore, Lonza Group, Pan-Biotech GmbH, GE Healthcare Life Sciences, CellGenix GmbH, Corning Incorporated, Sartorius Stedim Biotech, BD Biosciences, HiMedia Laboratories, Samsung Biologics, Miltenyi Biotec, and Fujifilm Irvine Scientific.

Key Developments:

In March 2025, Bio-Techne Corporation announced that Asuragen, a Bio-Techne brand, has teamed up with Oxford Nanopore Technologies to launch the AmplideX(R) Nanopore Carrier plus Kit, a new genetic panel and supporting analysis software for carrier screening research. This innovative kit helps laboratories resolve genes that are challenging to analyze by conventional short-read sequencing and only partially resolved by ancillary assays.

In February 2025, Thermo Fisher Scientific Inc., announced the launch of the CorEvitas Systemic Lupus Erythematosus (SLE) Registry. The multi-center, prospective registry leverages the CorEvitas rheumatology physician network and addresses a critical unmet need for collecting robust, objective real-world data about this chronic and devastating autoimmune disease, in which the immune system attacks healthy tissue and can cause damage to patients' skin, joints, blood and internal organs, including the kidneys, heart, brain and lungs.

Product Types Covered:

  • Natural Media
  • Synthetic Media
  • Semi-synthetic Media
  • Serum-free Media
  • Custom Media
  • Classical Media
  • Chemically Defined Media
  • Other Product Types

Cell Types Covered:

  • Mammalian Cells
  • Insect Cells
  • Microbial Cells
  • Primary Cells
  • Immortalized Cell Lines

Formulation Types Covered:

  • Powder Formulation
  • Liquid Formulation
  • Concentrates

Applications Covered:

  • Drug Development & Testing
  • Regenerative Medicine
  • Biologics Production
  • Cancer Research
  • Stem Cell Research
  • Tissue Engineering
  • Other Applications

End Users Covered:

  • Pharmaceutical and Biotechnology
  • Research and Academic Institutes
  • Contract Research Organizations (CROs)
  • Hospitals and Diagnostic Laboratories
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Cell Culture Media Market, By Product Type

  • 5.1 Introduction
  • 5.2 Natural Media
  • 5.3 Synthetic Media
  • 5.4 Semi-synthetic Media
  • 5.5 Serum-free Media
    • 5.5.1 CHO Media
    • 5.5.2 HEK 293 Media
    • 5.5.3 BHK Medium
    • 5.5.4 Vero Medium
  • 5.6 Custom Media
  • 5.7 Classical Media
  • 5.8 Chemically Defined Media
  • 5.9 Other Product Types

6 Global Cell Culture Media Market, By Cell Type

  • 6.1 Introduction
  • 6.2 Mammalian Cells
  • 6.3 Insect Cells
  • 6.4 Microbial Cells
  • 6.5 Primary Cells
  • 6.6 Immortalized Cell Lines

7 Global Cell Culture Media Market, By Formulation Type

  • 7.1 Introduction
  • 7.2 Powder Formulation
  • 7.3 Liquid Formulation
  • 7.4 Concentrates

8 Global Cell Culture Media Market, By Application

  • 8.1 Introduction
  • 8.2 Drug Development & Testing
  • 8.3 Regenerative Medicine
  • 8.4 Biologics Production
  • 8.5 Cancer Research
  • 8.6 Stem Cell Research
  • 8.7 Tissue Engineering
  • 8.8 Other Applications

9 Global Cell Culture Media Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmaceutical and Biotechnology
  • 9.3 Research and Academic Institutes
  • 9.4 Contract Research Organizations (CROs)
  • 9.5 Hospitals and Diagnostic Laboratories
  • 9.6 Other End Users

10 Global Cell Culture Media Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Thermo Fisher Scientific, Inc.
  • 12.2 Bio-Techne Corporation
  • 12.3 Sigma-Aldrich
  • 12.4 Merck Millipore
  • 12.5 Lonza Group
  • 12.6 Pan-Biotech GmbH
  • 12.7 GE Healthcare Life Sciences
  • 12.8 CellGenix GmbH
  • 12.9 Corning Incorporated
  • 12.10 Sartorius Stedim Biotech
  • 12.11 BD Biosciences
  • 12.12 HiMedia Laboratories
  • 12.13 Samsung Biologics
  • 12.14 Miltenyi Biotec
  • 12.15 Fujifilm Irvine Scientific

List of Tables

  • Table 1 Global Cell Culture Media Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Cell Culture Media Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Cell Culture Media Market Outlook, By Natural Media (2024-2032) ($MN)
  • Table 4 Global Cell Culture Media Market Outlook, By Synthetic Media (2024-2032) ($MN)
  • Table 5 Global Cell Culture Media Market Outlook, By Semi-synthetic Media (2024-2032) ($MN)
  • Table 6 Global Cell Culture Media Market Outlook, By Serum-free Media (2024-2032) ($MN)
  • Table 7 Global Cell Culture Media Market Outlook, By CHO Media (2024-2032) ($MN)
  • Table 8 Global Cell Culture Media Market Outlook, By HEK 293 Media (2024-2032) ($MN)
  • Table 9 Global Cell Culture Media Market Outlook, By BHK Medium (2024-2032) ($MN)
  • Table 10 Global Cell Culture Media Market Outlook, By Vero Medium (2024-2032) ($MN)
  • Table 11 Global Cell Culture Media Market Outlook, By Custom Media (2024-2032) ($MN)
  • Table 12 Global Cell Culture Media Market Outlook, By Classical Media (2024-2032) ($MN)
  • Table 13 Global Cell Culture Media Market Outlook, By Chemically Defined Media (2024-2032) ($MN)
  • Table 14 Global Cell Culture Media Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 15 Global Cell Culture Media Market Outlook, By Cell Type (2024-2032) ($MN)
  • Table 16 Global Cell Culture Media Market Outlook, By Mammalian Cells (2024-2032) ($MN)
  • Table 17 Global Cell Culture Media Market Outlook, By Insect Cells (2024-2032) ($MN)
  • Table 18 Global Cell Culture Media Market Outlook, By Microbial Cells (2024-2032) ($MN)
  • Table 19 Global Cell Culture Media Market Outlook, By Primary Cells (2024-2032) ($MN)
  • Table 20 Global Cell Culture Media Market Outlook, By Immortalized Cell Lines (2024-2032) ($MN)
  • Table 21 Global Cell Culture Media Market Outlook, By Formulation Type (2024-2032) ($MN)
  • Table 22 Global Cell Culture Media Market Outlook, By Powder Formulation (2024-2032) ($MN)
  • Table 23 Global Cell Culture Media Market Outlook, By Liquid Formulation (2024-2032) ($MN)
  • Table 24 Global Cell Culture Media Market Outlook, By Concentrates (2024-2032) ($MN)
  • Table 25 Global Cell Culture Media Market Outlook, By Application (2024-2032) ($MN)
  • Table 26 Global Cell Culture Media Market Outlook, By Drug Development & Testing (2024-2032) ($MN)
  • Table 27 Global Cell Culture Media Market Outlook, By Regenerative Medicine (2024-2032) ($MN)
  • Table 28 Global Cell Culture Media Market Outlook, By Biologics Production (2024-2032) ($MN)
  • Table 29 Global Cell Culture Media Market Outlook, By Cancer Research (2024-2032) ($MN)
  • Table 30 Global Cell Culture Media Market Outlook, By Stem Cell Research (2024-2032) ($MN)
  • Table 31 Global Cell Culture Media Market Outlook, By Tissue Engineering (2024-2032) ($MN)
  • Table 32 Global Cell Culture Media Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 33 Global Cell Culture Media Market Outlook, By End User (2024-2032) ($MN)
  • Table 34 Global Cell Culture Media Market Outlook, By Pharmaceutical and Biotechnology (2024-2032) ($MN)
  • Table 35 Global Cell Culture Media Market Outlook, By Research and Academic Institutes (2024-2032) ($MN)
  • Table 36 Global Cell Culture Media Market Outlook, By Contract Research Organizations (CROs) (2024-2032) ($MN)
  • Table 37 Global Cell Culture Media Market Outlook, By Hospitals and Diagnostic Laboratories (2024-2032) ($MN)
  • Table 38 Global Cell Culture Media Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.